Shelley JambresicGroup Lead Science & Evaluation at Geistlich Pharma AGSpeaker, Advisor
Profile
Shelley Jambresic is a Group Lead Science & Evaluation at Geistlich Pharma, responsible for clinical evaluation and clinical data interpretation of class III medical devices of animal origin. She is experienced in planning and conducting pre- and post-market clinical trials with medical devices and had the lead for implementation of MDR requirements in clinical processes at Geistlich Pharma. By training, Shelley Jambresic is a microbiologist and science communicator with extensive experience in medical and science writing.
Agenda Sessions
Panel: Clinical and Performance Evidence Expectations: Are We Finally Aligned?
, 17:00View Session